Non-Billable / Non-Specific Code
ICD-10-CM C88.9 is the diagnosis code for Malignant immunoproliferative disease, unspecified. This code falls under the section "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where C88.9 sits in the ICD-10-CM classification helps ensure proper coding:
No, C88.9 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C88.9 is the ICD-10-CM diagnosis code for "Malignant immunoproliferative disease, unspecified". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C88.9 is C88 ("Malignant immunoproliferative diseases and certain other B-cell lymphomas"). C88.9 provides a more specific classification within this category.
C88.9 is located in Section C81-C96 — "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 of the ICD-10-CM Tabular List.
C88.9 has 1918 sub-code(s) that provide more specific detail: A00, A01, A02, A03, A04 and more.
Use C88.9 when the patients documented diagnosis matches "Malignant immunoproliferative disease, unspecified" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant immunoproliferative disease, unspecified is C88.9.
No, C88.9 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C88.9 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C88.9 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.